Close monitoring of HIV viral load is crucial to prevent LLV among HIV-positive patients on ART, particularly older adults with low CD4+ counts and a history of PI use.

HIV’s Tat protein blocks autophagy in macrophages, letting Mtb thrive. This may explain why HIV patients face higher TB risk even on ART.

The stock-trading website Raging Bull just gave Cocrystal Pharma, a clinical-stage biotech, a big thumbs up for its ...

The EU has given Gilead the green light to market its twice-yearly pre-exposure prophylaxis (PrEP) product lenacapavir, which is viewed as a key part of the drugmaker's growth strategy in HIV. The ...